Concepedia

Katherine Kravik

KK

Statistics

Publications

10

Citations

749

H-Index

10

Active since

1992

Affiliations

Med-Storm Innovation (Norway)(Current)

University of Oslo

Rigshospitalet

Katherine Kravik is an author at Med-Storm Innovation (Norway) specializing in medicine, oncology, and apoptosis.

Publications per year

1992–2008

10

Publications

10

Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery

Paula M. De Angelis, Debbie Hege Svendsrud, Katherine Kravik et al. · Molecular Cancer · 2006 · 233 citations · Full text

, , +17

Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols.

Paula M. De Angelis, Katherine Kravik, Siv H. Tunheim et al. · Molecular Cancer · 2004 · 204 citations · Full text

, , +14

Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil

P. De Angelis, Bjørg Fjell, Katherine Kravik et al. · International Journal of Oncology · 2004 · 101 citations

, , +15

Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment

Birgitte Lid Adamsen, Katherine Kravik, O. P. F. Clausen et al. · International Journal of Oncology · 2007 · 59 citations · Full text

, , +17

Subcellular Localization of the Spindle Proteins Aurora A, Mad2, and BUBR1 Assessed by Immunohistochemistry

Espen Burum‐Auensen, Paula M. De Angelis, Aasa R. Schjølberg et al. · Journal of Histochemistry & Cytochemistry · 2007 · 57 citations · Full text

, , +17

1–5 of 10